US FDA transparency meeting scheduled for November
This article was originally published in Clinica
Executive Summary
US President Barack Obama’s promise to achieve “an unprecedented level of openness in Government” continues to make itself manifest at the FDA with the second public meeting now scheduled on transparency at the agency.